Tenacibaculum maritimum in Marine Fish: Ulcer Disease in Halibut, Sea Bass, and Other Species

Introduction

Tenacibaculum maritimum is a Gram-negative, filamentous, gliding bacterium belonging to the family Flavobacteriaceae within the phylum Bacteroidetes. This pathogen is the primary etiological agent of tenacibaculosis, a disease complex characterized by ulcerative skin lesions, fin rot, and systemic infections in a wide range of marine fish species [1]. The disease is of significant economic and veterinary concern in global aquaculture, particularly in cold-water and temperate marine finfish production systems. T. maritimum has been isolated from cultured populations of olive flounder (Paralichthys olivaceus), European sea bass (Dicentrarchus labrax), Atlantic halibut (Hippoglossus hippoglossus), and other commercially important species [1, 2]. The pathogen is also capable of infecting wild-caught fish, including Pacific salmon (Oncorhynchus spp.), as documented in recent surveillance studies [2].

The clinical presentation of tenacibaculosis is dominated by external ulcerative lesions that progress from superficial epidermal erosions to deep dermal and subdermal necrotic ulcers. These lesions frequently involve the underlying musculature and can lead to secondary osseous exposure. The disease is associated with high morbidity and variable mortality depending on water temperature, host immune status, and the presence of concurrent stressors or co-infections [1, 3]. Understanding the biological, biophysical, and molecular mechanisms of T. maritimum pathogenesis is essential for developing effective diagnostic, therapeutic, and prophylactic strategies in marine aquaculture.

Taxonomy and Bacteriological Characteristics

T. maritimum is a strictly marine, halophilic bacterium that requires sodium chloride for growth. The organism is characterized by its filamentous morphology, with cells ranging from 2 to 30 micrometers in length and 0.3 to 0.5 micrometers in width [1]. The bacterium exhibits gliding motility on solid surfaces, a trait mediated by type IX secretion system (T9SS) components that facilitate translocation across agar and biofilm matrices. Colony morphology on marine agar is typically yellow-pigmented, flat, and spreading with irregular edges. The yellow pigmentation is attributed to flexirubin-type pigments, which are non-diffusible and characteristic of the genus [1].

Biochemically, T. maritimum is oxidase-positive, catalase-positive, and capable of hydrolyzing casein, gelatin, and starch. The organism does not produce acid from carbohydrates and is non-fermentative. Optimal growth temperatures range from 15 to 25 degrees Celsius, with maximal growth at 20 degrees Celsius for most isolates [1]. The bacterium is strictly aerobic and requires seawater-based media for primary isolation. Growth is inhibited at temperatures exceeding 30 degrees Celsius, which limits its geographic distribution to temperate and cold-water marine environments.

Host Range and Geographic Distribution

T. maritimum has been documented in a broad spectrum of marine fish hosts. The primary cultured species affected include olive flounder (Paralichthys olivaceus) in East Asian aquaculture, European sea bass (Dicentrarchus labrax) in Mediterranean and European marine farms, and Atlantic halibut (Hippoglossus hippoglossus) in North Atlantic cold-water production systems [1, 3]. The pathogen has also been isolated from other flatfish species, including turbot (Scophthalmus maximus) and sole (Solea spp.), as well as from gadoids such as Atlantic cod (Gadus morhua) [1].

Recent surveillance efforts have expanded the known host range to include wild-caught Pacific salmon (Oncorhynchus spp.) [2]. The isolation of T. maritimum from wild salmon populations indicates that the pathogen is not restricted to intensive aquaculture environments and can circulate in natural marine ecosystems. This finding has implications for the management of wild fish stocks and the potential for transmission between farmed and wild fish populations [2].

Geographic distribution of tenacibaculosis includes the Northeast Atlantic, the Mediterranean Sea, the Pacific coast of Asia, and the Pacific Northwest of North America. The disease is most frequently reported during the spring and autumn months when water temperatures are within the optimal range for bacterial proliferation [1].

Pathogenesis and Virulence Mechanisms

The pathogenesis of T. maritimum is initiated by adhesion to the host epidermis, followed by colonization and invasion of the integumentary system. The bacterium produces a range of extracellular enzymes, including proteases, collagenases, and hemolysins, that degrade host tissues and facilitate bacterial penetration [1]. The gliding motility of T. maritimum is a critical virulence factor, enabling the organism to move across fish skin surfaces and to penetrate through mucus layers and epithelial barriers.

The primary portal of entry is through the skin, with initial colonization occurring at sites of mechanical abrasion, scale loss, or fin damage. Once established, the bacterium proliferates within the epidermis and dermis, causing necrosis of keratinocytes and collagen degradation in the dermal matrix [1]. The resulting lesions are characterized by a loss of epithelial integrity, exposure of underlying connective tissue, and the formation of ulcerative craters. In severe cases, the infection extends into the underlying musculature, leading to myonecrosis and systemic dissemination.

The host immune response to T. maritimum infection involves both innate and adaptive components. The innate response is characterized by recruitment of macrophages and neutrophils to the site of infection, along with the production of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) [3]. The adaptive response involves the production of specific antibodies against bacterial surface antigens, including lipopolysaccharides and outer membrane proteins. However, the bacterium possesses mechanisms to evade host immune clearance, including the formation of biofilms and the modulation of host complement pathways [1].

Clinical Signs and Pathological Findings

The clinical presentation of tenacibaculosis is dominated by external integumentary lesions. The disease typically begins with the appearance of small, focal areas of epidermal discoloration and opacity, which progress to frank ulceration within 24 to 48 hours [1]. The ulcers are characteristically well-demarcated, with raised, erythematous margins and a necrotic, yellow-white base. Lesions are most commonly observed on the head, operculum, flanks, and caudal peduncle. Fin rot, characterized by progressive erosion and fragmentation of the fin rays, is a frequent concurrent finding.

In olive flounder, the lesions are typically located on the blind side (ventral surface) and the ocular side (dorsal surface) of the body, with a predilection for the caudal region [1]. In European sea bass, lesions are most frequently observed on the dorsal surface, particularly around the dorsal fin insertion and the caudal peduncle [3]. In Atlantic halibut, the disease presents as multifocal, coalescing ulcers on the body surface, with a tendency for lesion formation on the head and opercular region.

Systemic signs of infection include lethargy, anorexia, and abnormal swimming behavior. Affected fish often exhibit a loss of equilibrium and may be observed swimming at the water surface or in the corners of tanks. Mortality is typically acute, with death occurring within 3 to 7 days of the onset of clinical signs in severe cases [1].

Histopathological examination of ulcerative lesions reveals extensive necrosis of the epidermis and dermis, with infiltration of inflammatory cells. The dermal collagen fibers are fragmented and degraded, and the underlying musculature shows evidence of myofiber degeneration and necrosis [1]. In chronic cases, the lesions may be surrounded by a zone of fibroplasia and granulation tissue formation.

Diagnostic Approaches

The diagnosis of tenacibaculosis is based on a combination of clinical observation, histopathology, and microbiological culture. The definitive diagnosis requires the isolation and identification of T. maritimum from affected tissues. Standard culture methods involve the use of marine agar or cytophaga agar supplemented with seawater. Inoculation of lesion swabs or tissue homogenates onto these media and incubation at 20 to 25 degrees Celsius for 48 to 72 hours yields characteristic yellow-pigmented, spreading colonies [1].

Biochemical identification is based on the organism's profile of enzymatic activities, including positive reactions for oxidase, catalase, and gelatin hydrolysis. The bacterium is negative for the production of acid from carbohydrates and for the fermentation of glucose [1]. Molecular identification using species-specific polymerase chain reaction (PCR) assays targeting the 16S ribosomal RNA gene is a rapid and sensitive alternative to culture-based methods. PCR assays can be applied directly to tissue samples or to bacterial isolates, providing confirmation within hours [1].

Serological methods, including enzyme-linked immunosorbent assay (ELISA) and agglutination tests, have been developed for the detection of antibodies against T. maritimum in fish sera. These assays are useful for surveillance and for assessing the immune status of populations following vaccination or natural exposure [3]. The ELISA format typically uses whole-cell bacterial antigens or purified outer membrane proteins as the coating antigen, with detection via species-specific anti-immunoglobulin conjugates.

Differential Diagnosis

The differential diagnosis for ulcerative skin lesions in marine fish includes several other bacterial and parasitic pathogens. The primary differentials are:

• Vibrio anguillarum: Causes vibriosis, which presents with hemorrhagic septicemia and skin ulcers. The lesions are typically more hemorrhagic and less well-demarcated than those of tenacibaculosis.
• Aeromonas salmonicida: The agent of furunculosis in salmonids, which produces characteristic furuncles (boil-like lesions) in the musculature.
• Pseudomonas spp.: Opportunistic pathogens that can cause secondary skin infections in stressed fish.
• Parasitic infections: Including sea lice (Lepeophtheirus salmonis) and monogenean trematodes, which cause mechanical damage to the skin and can predispose to secondary bacterial infection.

The differentiation of T. maritimum from other gliding bacteria, such as Tenacibaculum soleae and Tenacibaculum discolor, requires molecular confirmation via 16S rRNA gene sequencing or species-specific PCR [1].

Treatment and Control Strategies

The management of tenacibaculosis in marine aquaculture relies on a combination of antimicrobial therapy, biosecurity measures, and host immune enhancement. Antimicrobial treatment is typically administered via medicated feed or bath treatments. The use of antibiotics, including oxytetracycline, florfenicol, and amoxicillin, has been reported for the control of T. maritimum infections [1]. However, the emergence of antimicrobial resistance is a growing concern, and susceptibility testing should be performed on a per-isolate basis to guide therapeutic choices.

The use of dietary immunostimulants has been investigated as a prophylactic strategy to enhance host resistance to T. maritimum infection. The administration of 1.3-1.6 beta-glucans derived from yeast (Saccharomyces cerevisiae) has been shown to improve immune response and disease resilience in European sea bass challenged with T. maritimum [3]. The beta-glucans act through the activation of pattern recognition receptors, including dectin-1 and complement receptor 3, leading to enhanced phagocytic activity and respiratory burst in macrophages. The dietary supplementation of beta-glucans at inclusion rates of 0.1% to 0.2% of the feed has been associated with reduced mortality and lesion severity following experimental challenge [3].

Vaccination strategies for T. maritimum have been developed using inactivated whole-cell bacterins and subunit vaccines. The administration of these vaccines via injection or immersion has been shown to elicit protective antibody responses and to reduce the severity of clinical disease [1]. The development of effective vaccines is complicated by the genetic diversity of T. maritimum isolates and the need for multivalent formulations to cover the range of circulating serotypes.

Biosecurity measures, including the maintenance of optimal water quality, the reduction of stocking densities, and the minimization of handling stress, are critical for the prevention of tenacibaculosis outbreaks. The removal of dead and moribund fish from the population is essential to reduce the bacterial load in the water column and to limit horizontal transmission [1].

Host Immune Response and Immunological Mechanisms

The host immune response to T. maritimum infection is a complex interplay between innate and adaptive immune mechanisms. The innate immune system provides the first line of defense through the recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) on host cells. The recognition of bacterial lipopolysaccharides, flagellin, and peptidoglycan by Toll-like receptors (TLRs) on macrophages and dendritic cells triggers the activation of nuclear factor kappa B (NF-κB) and the production of pro-inflammatory cytokines [3].

The adaptive immune response is initiated through the processing and presentation of bacterial antigens by major histocompatibility complex (MHC) class I and class II molecules. The activation of T helper cells (Th1 and Th2) leads to the production of specific antibodies by B cells and the generation of cytotoxic T cell responses [3]. The antibody response is directed against surface antigens, including lipopolysaccharides and outer membrane proteins, and is associated with the opsonization and neutralization of the bacterium.

The use of dietary beta-glucans has been shown to modulate the immune response in European sea bass, with effects on both the innate and adaptive arms. The administration of 1.3-1.6 beta-glucans at 0.1% of the diet for 4 weeks prior to challenge resulted in increased expression of genes encoding for interleukin-1 beta, tumor necrosis factor alpha, and major histocompatibility complex class II [3]. The enhanced immune response was associated with a reduction in the severity of clinical lesions and a decrease in the bacterial load in the tissues of challenged fish.

Epidemiological Considerations

The epidemiology of tenacibaculosis is influenced by a range of environmental and host factors. Water temperature is the primary environmental determinant, with the disease occurring most frequently at temperatures between 15 and 20 degrees Celsius [1]. The incidence of disease is typically higher during the spring and autumn months when water temperatures are within this range and when fish are undergoing the physiological stress of seasonal temperature changes.

The role of stress in the pathogenesis of tenacibaculosis is well established. Handling, transport, and crowding are known to increase the susceptibility of fish to infection through the elevation of plasma cortisol levels and the suppression of immune function [1]. The presence of concurrent infections, including viral and parasitic pathogens, can also exacerbate the severity of tenacibaculosis.

The transmission of T. maritimum is primarily horizontal, with the bacterium being shed from infected fish into the water column and transmitted to naive fish through direct contact or through the water. The bacterium can survive in the marine environment for extended periods, particularly in association with biofilms on tank surfaces and netting [1]. The persistence of the pathogen in the environment is a significant challenge for the control of the disease in recirculating aquaculture systems.

Future Directions and Research Priorities

The continued development of molecular diagnostic tools, including quantitative PCR (qPCR) and loop-mediated isothermal amplification (LAMP) assays, is a priority for the rapid and sensitive detection of T. maritimum in fish and environmental samples. The application of high-throughput sequencing technologies to the characterization of T. maritimum genomes will provide insights into the genetic basis of virulence and the mechanisms of antimicrobial resistance [1].

The development of effective vaccines against T. maritimum is a key research priority. The identification of protective antigens and the optimization of vaccine delivery systems, including the use of adjuvants and nanoparticle-based formulations, are areas of active investigation [3]. The use of reverse vaccinology approaches, which involve the in silico prediction of vaccine targets from genomic sequences, offers a promising pathway for the development of next-generation vaccines.

The investigation of the role of the fish microbiome in resistance to T. maritimum infection is an emerging area of research. The modulation of the skin and gut microbiota through the use of probiotics and prebiotics may provide a novel approach to enhancing host resistance and reducing the incidence of tenacibaculosis [1].

Conclusion

Tenacibaculum maritimum is a significant bacterial pathogen of marine fish, responsible for ulcerative skin disease and tenacibaculosis in a range of commercially important species including olive flounder, European sea bass, and Atlantic halibut. The pathogen is also capable of infecting wild-caught Pacific salmon, indicating a broader host range than previously recognized [2]. The diagnosis of tenacibaculosis relies on a combination of clinical observation, histopathology, and microbiological culture, with molecular methods providing rapid and sensitive confirmation. The management of the disease requires a multifaceted approach that includes antimicrobial therapy, biosecurity measures, and the use of dietary immunostimulants such as beta-glucans to enhance host immune function [3]. Continued research into the pathogenesis, epidemiology, and control of T. maritimum is essential for the sustainability of marine aquaculture and the health of wild fish populations.

References

[1] Jang Y, Jeong J, Yeo I, et al. Biological characterization of Tenacibaculum maritimum isolated from cultured olive flounder in Korea and sensitivity against native plant extracts. Journal. 2009. Available at: https://www.semanticscholar.org/paper/c5699939a5217d0c76f33f0463fe632e4b646231

[2] Di Cicco E, Godwin SC, Zinn KR, et al. First report of tenacibaculosis in wild-caught Pacific salmon. Sci Rep. 2026. Available at: https://pubmed.ncbi.nlm.nih.gov/42288529/

[3] Cabano M, Richard N, Schulthess J, et al. Dietary 1.3-1.6 yeast beta-glucans enhance immune response and disease resilience in European seabass challenged with Tenacibaculum maritimum. Front Immunol. 2026. Available at: https://pubmed.ncbi.nlm.nih.gov/42088490/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.